Abstract
Patients with cancer are at increased risk of SARA-CoV-2 infection or developing severe COVID-19 cases due to the malignancy or immunosuppressive therapy, but they are generally excluded from the target population for COVID-19 vaccination. In general, inactivated vaccines are safe and immunogenic for patients with cancer, but live attenuated vaccines are not recommended. The study suggested that the safety of the mRNA COVID-19 vaccine in cancer patients is similar to that in healthy people, but the immunogenicity is slightly weaker, and a booster dose may be needed. This paper aims to summarize the results of COVID-19 vaccine clinical studies conducted in cancer patients worldwide and the relevant guidelines released by authorities, so as to provide evidence for promoting COVID-19 vaccination for cancer patients.
Highlights
Cancer is a complex disease which impacts patients including those with active disease, on anticancer treatment, with chronic disease after treatment, or cancer survivors[1]
A number of studies around the world have reported that COVID-19 patients with cancer develop a higher risk for severe disease and case fatality rate from SARS
A prospective observational study in the UK including 800 symptomatic COVID-19 patients with cancer observed no significant difference in the mortality for the patients with chemotherapy and patients with other anticancer treatment[8], and Chinese patients in the early period epidemic who undergone only radiotherapy did not demonstrate higher incidence of severe events compared with patients without cancer[9]
Summary
Corresponding authors: Fengcai Zhu, Jiangsu Provincial Center for Disease Control and Prevention, 172. Potential conflicts of interest: No potential conflicts of interest were disclosed. NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center. Jiangsu Cancer Hospital, Affiliated Cancer Hospital of Nanjing Medical University, ce
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.